Dynamic and heterogeneous mutations to fluconazole resistance in Cryptococcus neoformans

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 2, 2001, Pages 420-427

  Xu, J ^a   Onyewu, C ^a   Yoell, H J ^a   Ali, R Y ^a   Vilgalys, R J ^a   Mitchell, T G ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ARTICLE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GENETIC HETEROGENEITY; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DNA FINGERPRINTING; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; GENOTYPE; MICROBIAL SENSITIVITY TESTS; MUTATION; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 0035139528     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.2.420-427.2001     Document Type: Article

References (36)

1. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis
2. The hidden danger of primary fluconazole prophylaxis for patients with AIDS
3. Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis
4. Pharmacokinetics and tissue penetration of fluconazole in human
5. Multilocus enzyme typing of Cryptococcus neoformans
6. Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated cryptococcosis
7. Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States
8. Cryptococcus neoformans
9. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole
10. Rates of spontaneous mutations
11. Antifungal agents and susceptibility tests
12. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains
13. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes
14. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents
15. Evaluation of a new method for identification of Cryptococcus neoformans which uses serologic tests aided by selected biological tests
16. Update on antifungal resistance
17. Variation in electrophoretic karyotype and antifungal susceptibility of clinical isolates of Cryptococcus neoformans at a university-affiliated teaching hospital from 1987 to 1994
18. High mutation frequencies among Escherichia coli and Salmonella pathogens
19. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR
20. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans
21. Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans
22. Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis
23. Cryptococcemia
24. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients
25. Persistence, replacement and microevolution of Cryptococcus neoformans strains in recurrent meningitis in AIDS patients
26. Antifungal drug resistance in pathogenic fungi
27. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
28. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans
29. Fluconazole: Comparison of pharmacokinetics, therapy and in vitro susceptibility
30. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: The role of antifungal susceptibility testing
31. Clonal and spontaneous origins of fluconazole resistance in Candida albicans
32. Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts